Galectin Therapeutics, Inc. (GALT)
3.53
-0.09
(-2.49%)
USD |
NASDAQ |
Oct 19, 14:02
Galectin Therapeutics Cash from Operations (Annual) : -23.88M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -23.88M |
| December 31, 2024 | -41.77M |
| December 31, 2023 | -32.96M |
| December 31, 2022 | -31.06M |
| December 31, 2021 | -24.31M |
| December 31, 2020 | -20.60M |
| December 31, 2019 | -10.85M |
| December 31, 2018 | -10.18M |
| December 31, 2017 | -15.89M |
| December 31, 2016 | -16.41M |
| December 31, 2015 | -16.98M |
| December 31, 2014 | -12.43M |
| December 31, 2013 | -7.484M |
| Date | Value |
|---|---|
| December 31, 2012 | -7.50M |
| December 31, 2011 | -5.676M |
| December 31, 2010 | -3.102M |
| December 31, 2009 | -3.887M |
| December 31, 2008 | -4.665M |
| December 31, 2007 | -5.483M |
| December 31, 2006 | -6.757M |
| December 31, 2005 | -6.127M |
| December 31, 2004 | -6.333M |
| December 31, 2003 | -4.152M |
| December 31, 2002 | -2.983M |
| December 31, 2001 | -1.799M |
| December 31, 2000 | -0.0891M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Mirum Pharmaceuticals, Inc. | 55.83M |
| ACADIA Pharmaceuticals, Inc. | 109.84M |
| Alnylam Pharmaceuticals, Inc. | 524.08M |
| Anika Therapeutics, Inc. | 11.19M |
| Savara, Inc. | -101.04M |